Yourgene Health PLC - Manchester-based molecular diagnostics group - Gets CE-IVD marking for its Clarigene SARS-CoV-2 in vitro diagnostic kit. The CE-IVD version of the Clarigene SARS-CoV-2 test will allow Yourgene to provide corporate partners and healthcare settings, such as care homes and private GP practices, with a fast and reliable Covid-19 lab testing service. Clinical validation of the test kit has shown 99.9% accuracy with no false positive or false negative results. Additional studies have shown 100% repeatability data and an average 99.7% reproducibility. The Clarigene test only detects SARS CoV-2 RNA and shows no cross reactivity with other respiratory viruses.
Current stock price: 18.18 pence
Year-to-date change: up 37%
By Tapan Panchal; email@example.com
Copyright 2020 Alliance News Limited. All Rights Reserved.